Start › Nowotwór przerzutowy › Ohio › Cleveland
Badania kliniczne dla Nowotwór przerzutowy w mieście Cleveland, OH
30 badań dla Nowotwór przerzutowy szuka uczestników w ośrodkach w mieście Cleveland i okolicach (w promieniu ok. 30 mil). Otwórz badanie, aby zobaczyć kryteria kwalifikacji i dane kontaktowe zespołu badawczego.
Oficjalny tekst badania (angielski)
Rekrutujesz uczestników do badania? Wyróżnij je na górze tej strony – $99 za 30 dni →
BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)
RekrutacjaFaza 1/2
- Avenzo Therapeutics Recruiting Site, Cleveland
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RekrutacjaFaza 2
- Case Western Reserve University, Cleveland
- UHHS-Chagrin Highlands Medical Center, Beachwood · 10 mi dalej
- UH Seidman Cancer Center at Lake Health Mentor Campus, Mentor · 22 mi dalej
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
RekrutacjaFaza 1
- University Hospitals Cleveland Medical Center, Cleveland
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RekrutacjaFaza 1/2
- The Cleveland Clinic Taussig Cancer Center, Cleveland
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
RekrutacjaFaza 1
- University Hospitals Cleveland Medical Center, Cleveland
- Cleveland Clinic, Cleveland
A Study of ASP3082 in Adults With Advanced Solid Tumors
RekrutacjaFaza 1
- Case Western, Cleveland
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
RekrutacjaFaza 2/3
- University Hospitals Cleveland Medical Center, Cleveland
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RekrutacjaFaza 3
- University Hospitals Cleveland Medical Center, Cleveland
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
RekrutacjaFaza 3
- Research Site, Cleveland
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RekrutacjaFaza 3
- University Hospitals Cleveland Medical Center, Cleveland
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
RekrutacjaFaza 3
- University Hospitals Cleveland Medical Center, Cleveland
- Fairview Hospital, Cleveland
- Cleveland Clinic, Cleveland
- i 1 więcej
SLV-154 Treatment of Advanced Cancers
RekrutacjaFaza 1
- University Hospitals Cleveland Medical Center, Cleveland
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RekrutacjaFaza 3
- University Hospitals Cleveland Medical Center, Cleveland
- Fairview Hospital, Cleveland
- Cleveland Clinic - Hillcrest Hospital, Mayfield Heights · 12 mi dalej
Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors
RekrutacjaFaza 1/2
- University Hospitals Cleveland Medical Center, Cleveland
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
RekrutacjaFaza 3
- Cleveland Clinic, Cleveland
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
RekrutacjaFaza 1
- Cleveland Clinic, Cleveland
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
RekrutacjaFaza 1
- Cleveland Clinic, Cleveland
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RekrutacjaFaza 1/2
- University Hospitals Cleveland Medical Center, Seidman Cancer Center, Cleveland
- Cleveland Clinic, Cleveland
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
RekrutacjaFaza 3
- Research Site, Cleveland
- Research Site, Cleveland
A Study of ASP1002 in Adults for Treatment of Solid Tumors
RekrutacjaFaza 1
- University Hospitals of Cleveland, Cleveland
REMASTer: REcurrent Brain Metastases After SRS Trial
Rekrutacja
- Cleveland Clinic, Cleveland
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
RekrutacjaFaza 1
- Research Site, Cleveland
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
RekrutacjaFaza 1
- University Hospitals - UH Cleveland Medical Center, Cleveland
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
RekrutacjaFaza 2/3
- Louis Stokes VA Medical Center, Cleveland, OH, Cleveland
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
RekrutacjaFaza 1/2
- Cleveland Clinic, Cleveland
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
RekrutacjaFaza 3
- Cleveland Clinic, Cleveland
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekrutacjaBadanie obserwacyjne
- Massive Bio SYNERGY-AI site, Mayfield Heights · 12 mi dalej
Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.
RekrutacjaFaza 1
- University Hospitals Cleveland Medical Center, Cleveland
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
RekrutacjaFaza 1/2
- Cleveland Clinic, Cleveland
A Study to Assess the Safety, Pharmacokinetics, and Antitumor Activity of BC3195 in Patients With Advanced or Metastatic Cancer
RekrutacjaFaza 1
- Case Western Reserve University, Cleveland
Badania dla Nowotwór przerzutowy w innych miastach
- Houston, TX104 badań
- New York City, NY93 badań
- Nashville, TN70 badań
- Boston, MA63 badań
- Los Angeles, CA57 badań
- St. Louis, MO54 badań
- Arlington, VA53 badań
- Philadelphia, PA46 badań
- Chicago, IL45 badań
- San Antonio, TX44 badań
- Washington, DC43 badań
- Dallas, TX42 badań
Inne badania w mieście Cleveland
- Niedrobnokomórkowy rak płuca43 badań
- Nowotwory (wszystkie typy)36 badań
- Rak piersi35 badań
- Rak prostaty34 badań
- Niewydolność serca33 badań
- Rak jajnika30 badań
- Rak płuc26 badań
- Rak jelita grubego i odbytnicy24 badań
- Choroby układu sercowo-naczyniowego22 badań
- Rak endometrium20 badań
- Ostra białaczka szpikowa20 badań
- Choroba Leśniowskiego-Crohna19 badań
Źródło: ClinicalTrials.gov, dane pobrane 6 paź 2026. Każde badanie ustala własne kryteria kwalifikacji; zespół badawczy decyduje, kto może wziąć udział.